phloretin has been researched along with Cancer of Lung in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temporary association of chitosan (CS)-coated nanoparticles (NPs) including phloretin (Phl) in the blood stream can be applied to treat lung metastasis of melanoma." | 7.91 | Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma. ( Cho, HJ; Koo, JS; Lee, SY; Yang, M, 2019) |
| "Temporary association of chitosan (CS)-coated nanoparticles (NPs) including phloretin (Phl) in the blood stream can be applied to treat lung metastasis of melanoma." | 3.91 | Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma. ( Cho, HJ; Koo, JS; Lee, SY; Yang, M, 2019) |
| "Phloretin (100 μM) treatment significantly inhibited the aldehyde dehydrogenase 1 activity of SiHa cells, reduced the self-renewal properties and stemness signatures of CD44 and Sox-2 in sphere-forming cervical cancer-derived tumor-initiating cells, and inhibited the invasion, MMP-2 activity, and tube formation capacity of human umbilical vein endothelial cells." | 1.51 | Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells. ( Chen, PN; Chen, SP; Hsiao, YH; Hsieh, MJ; Tsai, WC; Yang, SF, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunimasa, K | 1 |
| Nagano, T | 1 |
| Shimono, Y | 1 |
| Dokuni, R | 1 |
| Kiriu, T | 1 |
| Tokunaga, S | 1 |
| Tamura, D | 1 |
| Yamamoto, M | 1 |
| Tachihara, M | 1 |
| Kobayashi, K | 1 |
| Satouchi, M | 1 |
| Nishimura, Y | 1 |
| Aksorn, N | 1 |
| Chanvorachote, P | 1 |
| Lee, SY | 1 |
| Koo, JS | 1 |
| Yang, M | 1 |
| Cho, HJ | 1 |
| Hsiao, YH | 1 |
| Hsieh, MJ | 1 |
| Yang, SF | 1 |
| Chen, SP | 1 |
| Tsai, WC | 1 |
| Chen, PN | 1 |
| Ma, L | 1 |
| Wang, R | 1 |
| Nan, Y | 1 |
| Li, W | 1 |
| Wang, Q | 1 |
| Jin, F | 1 |
1 review available for phloretin and Cancer of Lung
| Article | Year |
|---|---|
Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer.
Topics: Antineoplastic Agents; Cell Adhesion; Cell Differentiation; Cell Proliferation; Cell Survival; Curcu | 2019 |
4 other studies available for phloretin and Cancer of Lung
| Article | Year |
|---|---|
Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Blotting, Western; Carcinoma, Non-Small-Cell Lung; | 2017 |
Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Drug | 2019 |
Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Gene Ex | 2019 |
Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase 9; Cell Line, T | 2016 |